Alzheimer's disease and the aging brain
- PMID: 16880353
- DOI: 10.1177/0891988706291079
Alzheimer's disease and the aging brain
Abstract
The frequencies of each of the several types of dementia are enumerated, showing that Alzheimer's disease is present in about 80% of cases. Cerebral changes associated with cognitively normal aging include shrinkage of large cortical neurons but not a significant loss of total neuronal number. Nevertheless, the population density of synapses measured by confocal microscopy does decline significantly in normal aging. The classical lesions of Alzheimer's disease are neuritic plaques and neurofibrillary tangles, and their frequency correlates with declining cognitive measures. Although amyloid is prominent in plaques, it is probably not the agent of destruction. That role seems to be held by Abeta oligomers. The strongest structural correlate with cognitive tests is synapse loss, which is probably caused by Abeta oligopeptides in the terminal axons and dendrites.
Similar articles
-
Alzheimer's neuroborreliosis with trans-synaptic spread of infection and neurofibrillary tangles derived from intraneuronal spirochetes.Med Hypotheses. 2007;68(4):822-5. doi: 10.1016/j.mehy.2006.08.043. Epub 2006 Oct 20. Med Hypotheses. 2007. PMID: 17055667
-
Pathological correlates of cognitive decline in Alzheimer's disease.Panminerva Med. 2007 Dec;49(4):191-5. Panminerva Med. 2007. PMID: 18091671 Review.
-
The combination of silver techniques for studying the pathology of Alzheimer's disease.Int J Neurosci. 2008 Feb;118(2):257-66. doi: 10.1080/00207450701591115. Int J Neurosci. 2008. PMID: 18205081
-
[The role of chronic brain hypoperfusion in the pathogenesis of Alzheimer's disease--facts and hypotheses].Ideggyogy Sz. 2007 Nov 30;60(11-12):428-37. Ideggyogy Sz. 2007. PMID: 18198789 Review. Hungarian.
-
Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.Brain. 2006 Nov;129(Pt 11):3020-34. doi: 10.1093/brain/awl255. Epub 2006 Sep 20. Brain. 2006. PMID: 16987932
Cited by
-
Asymptomatic neurotoxicity of amyloid β-peptides (Aβ1-42 and Aβ25-35) on mouse embryonic stem cell-derived neural cells.Bosn J Basic Med Sci. 2021 Feb 1;21(1):98-110. doi: 10.17305/bjbms.2020.4639. Bosn J Basic Med Sci. 2021. PMID: 32156249 Free PMC article.
-
Hippocampal Proteomic Analysis Reveals Distinct Pathway Deregulation Profiles at Early and Late Stages in a Rat Model of Alzheimer's-Like Amyloid Pathology.Mol Neurobiol. 2018 Apr;55(4):3451-3476. doi: 10.1007/s12035-017-0580-9. Epub 2017 May 13. Mol Neurobiol. 2018. PMID: 28502044
-
The S-Connect study: results from a randomized, controlled trial of Souvenaid in mild-to-moderate Alzheimer's disease.Alzheimers Res Ther. 2013 Nov 26;5(6):59. doi: 10.1186/alzrt224. eCollection 2013. Alzheimers Res Ther. 2013. PMID: 24280255 Free PMC article.
-
Nutritional modifiers of aging brain function: use of uridine and other phosphatide precursors to increase formation of brain synapses.Nutr Rev. 2010 Dec;68 Suppl 2(Suppl 2):S88-101. doi: 10.1111/j.1753-4887.2010.00344.x. Nutr Rev. 2010. PMID: 21091953 Free PMC article. Review.
-
Questions concerning the role of amyloid-β in the definition, aetiology and diagnosis of Alzheimer's disease.Acta Neuropathol. 2018 Nov;136(5):663-689. doi: 10.1007/s00401-018-1918-8. Epub 2018 Oct 22. Acta Neuropathol. 2018. PMID: 30349969 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical